Clinical Trial Update: Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of brolucizumab versus panretinal photocoagulation in proliferative diabetic retinopathy has completed, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• BEOVU (BROLUCIZUMAB)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Proliferative Diabetic Retinopathy | Phase 3 | Status: COMPLETED | Results posted: 2024-08-20